IV Amoxicillin Clavulanate

IV Amoxicillin Clavulanate

From The Canadian Breakpoint by Dr. Rupeena Purewal

October 24, 2025 · 23 min · Season 4 · Episode 3

About this episode

Dr. Rupeena Purewal discusses IV Amoxicillin Clavulanate with Dr. George Zhanel, highlighting the CLEAR Registry and its findings.

Dr. Rupeena Purewal welcomes back Dr. George Zhanel, Medical Microbiologist in Winnipeg and Research Director for CARA, to expand on The CLEAR Registry and spotlight clear results for IV Amoxicillin Clavulanate. To join CLEAR, email Dr. Zhanel at ggzhanel@pcsinternet.ca CARA www.can-r.com Canadian IV AmoxClav Product Monograph: 00074544.PDF Canadian collaborative AMR Awareness campaign: www.antibioticawareness.ca Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html

People in this episode

Host: Dr. Rupeena Purewal

Guest: Dr. George Zhanel

Topics covered

  • IV Amoxicillin Clavulanate
  • antimicrobial resistance
  • medical microbiology
  • CLEAR Registry
  • healthcare research

Keywords

  • IV Amoxicillin Clavulanate
  • CARA
  • CLEAR Registry
  • antimicrobial resistance
  • medical microbiology

Mentioned in this episode

Organizations: CARA, CLEAR Registry, Canadian IV AmoxClav Product Monograph, Canadian collaborative AMR Awareness campaign, Pan-Canadian Action on Antimicrobial Resistance

More episodes of The Canadian Breakpoint

Explore listener stats, chart rankings, contacts and more on the The Canadian Breakpoint podcast page.